CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246 | +2.1% | 21,074 | +17.1% | 0.00% | – |
| Q2 2023 | $241 | -37.2% | 17,996 | -22.4% | 0.00% | -100.0% |
| Q1 2023 | $384 | -48.5% | 23,178 | -42.3% | 0.00% | 0.0% |
| Q4 2022 | $746 | -99.7% | 40,158 | +73.6% | 0.00% | – |
| Q3 2022 | $296,000 | +86.2% | 23,126 | +1.8% | 0.00% | – |
| Q2 2022 | $159,000 | -72.7% | 22,708 | -67.7% | 0.00% | -100.0% |
| Q1 2022 | $582,000 | +1087.8% | 70,275 | +853.0% | 0.00% | – |
| Q4 2021 | $49,000 | +6.5% | 7,374 | -16.3% | 0.00% | – |
| Q3 2021 | $46,000 | -53.5% | 8,815 | -59.2% | 0.00% | – |
| Q1 2021 | $99,000 | +86.8% | 21,583 | +18.8% | 0.00% | – |
| Q3 2020 | $53,000 | +1.9% | 18,161 | +59.7% | 0.00% | – |
| Q2 2020 | $52,000 | +6.1% | 11,370 | -10.7% | 0.00% | – |
| Q1 2020 | $49,000 | +250.0% | 12,730 | +237.7% | 0.00% | – |
| Q4 2019 | $14,000 | – | 3,770 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |